REXISTA HC Canadian Trademark Information
Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and targeted release pharmaceutical preparations. Drug delivery systems, namely controlled timed release and targeted release pharmaceutical formulations provided as an integral component of pharmaceutical preparations; drug delivery systems, namely controlled timed released and targeted release pharmaceutical preparations, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations; pharmaceutical preparations incorporating controlled timed release and targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, all for the use in the treatment of attention deficit disorders, central nervous systems disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders , hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis.
Perfect for these industries
Words that describe this mark
research development services pharmaceutical sciences development application drug delivery technologies development controlled timed release targeted release pharmaceutical preparations drug delivery systems controlled timed release targeted release pharmaceutical formulations provided integral component pharmaceutical preparations
On Wednesday, August 27, 2014, a canadian trademark registration was filed for
REXISTA HC by INTELLIPHARMACEUTICS CORP *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1691435.
The current status of this trademark filing is Registration published.
The REXISTA HC
trademark is filed in the description of
Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and targeted release pharmaceutical preparations.
,
Drug delivery systems, namely controlled timed release and targeted release pharmaceutical formulations provided as an integral component of pharmaceutical preparations; drug delivery systems, namely controlled timed released and targeted release pharmaceutical preparations, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations; pharmaceutical preparations incorporating controlled timed release and targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, all for the use in the treatment of attention deficit disorders, central nervous systems disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders , hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.